3AF-14031-16074
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 272 / NC
- Registered
- 2021-09-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-03
Registered in v-safe
-
2021-09-03
Dose 1 — Pfizer-BioNTech
- 2021-09-03
- 2021-09-04
- 2021-09-05
-
2021-09-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-07
- 2021-09-08
- 2021-09-11
- 2021-09-19
-
2021-09-24
Dose 2 — Pfizer-BioNTech
-
2021-09-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-26
- 2021-09-27
- 2021-09-29
- 2021-09-30
- 2021-10-01
-
2021-10-08
Survey response — day 14, dose 2MedDRA: Oral herpes — Feeling: GoodFree text: Cold soreMedDRA releases: 2024-11 · check-in free text available
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-07
- 2021-12-24
- 2022-03-25
- 2022-09-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-03 | Pfizer-BioNTech | No |
| 2 | 2021-09-24 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2
Symptoms: Cold sore
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oral herpes | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release